87: Trajectories of antenatal depression and adverse pregnancy outcomes - 25/12/18
Doi : 10.1016/j.ajog.2018.11.096
Emily S. Miller 1, George R. Saade 2, Hyagriv N. Simhan 3, Catherine Monk 4, David M. Haas 5, Robert M. Silver 6, Brian M. Mercer 7, Jay D. Iams 8, Samuel Parry 9, Deborah A. Wing 10, Uma M. Reddy 11, William A. Grobman 1
1 Northwestern University Feinberg, School of Medicine, Chicago, IL
2 University of Texas Medal Branch, Galveston, TX
3 University of Pittsburgh, School of Medicine, Pittsburgh, PA
4 Columbia University, Medical Center, New York, NY
5 Indiana University, School of Medicine, Indianapolis, IN
6 University of Utah, School of Medicine, Salt Lake City, UT
7 Case Western Reserve University, School of Medicine, Cleveland, OH
8 The Ohio State University, College of Medicine , Columbus, OH
9 University of Pennsylvania, School of Medicine, Philadelphia, PA
10 University of California, Irvine School of Medicine, Irvine, CA
11 Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD
Le texte complet de cet article est disponible en PDF.
Plan
© 2018
Publié par Elsevier Masson SAS.
Vol 220 - N° 1S
P. S70 - janvier 2019 Retour au numéro
Article précédent
- 86: Brexanolone iv efficacy in postpartum depression in three pivotal trials: montgomery-åsberg depression rating scale assessment
- Christine Clemson, Samantha Meltzer-Brody, Helen Colquhoun, Robert Riesenberg, C.Neil Epperson, Kristina Deligiannidis, David Rubinow, Haihong Li, Stephen Kanes
- 88: Intensive glycemic control in gestational diabetes mellitus: a randomized controlled clinical trial
- Christina Scifres, Carolyn Mead-Harvey, Hugh Nadeau, Sean Reid, Stephanie Pierce, Maisa Feghali, Dean Myers, David Fields, Julie Stoner
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?